Sale!

BSCL2 Gene SPG17 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The BSCL2 Gene SPG17 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the BSCL2 gene, which is closely associated with Silver syndrome or distal hereditary motor neuropathy type V (dHMN-V), and a form of spastic paraplegia known as SPG17. This test is crucial for individuals displaying symptoms related to these conditions, as it can confirm the diagnosis and help in tailoring the management and treatment plans accordingly.

Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab. The sample is then analyzed using advanced genetic sequencing technologies to detect any abnormalities or mutations in the BSCL2 gene that could lead to the development of the aforementioned neurological disorders.

The cost of the BSCL2 Gene SPG17 Genetic Test at DNA Labs UAE is 4400 AED. This price includes the full process of sample collection, genetic analysis, and a comprehensive report detailing the findings. The report is an essential tool for healthcare providers in making informed decisions regarding the patient’s condition and in offering the appropriate genetic counseling for the patient and their family.

Given the complexity of genetic conditions, the BSCL2 Gene SPG17 Genetic Test is a valuable resource for individuals experiencing symptoms of Silver syndrome or SPG17, providing them with critical insights into their genetic makeup and guiding them towards effective management strategies.

Description

BSCL2 Gene SPG17 Genetic Test

Components:

Test Name: BSCL2 Gene SPG17 Genetic Test
Price: 4400.0 AED

Sample Condition:

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery:

3 to 4 Weeks

Method:

NGS Technology

Test Type:

Neurological Disorders

Doctor:

Neurologist

Test Department:

Genetics

Pre Test Information:

Clinical History of Patient who is going for BSCL2 Gene SPG17 NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with BSCL2 Gene SPG17

Test Details:

The BSCL2 gene, also known as SPG17, is responsible for producing a protein called seipin. Mutations in the BSCL2 gene can lead to a rare neurological disorder called spastic paraplegia type 17 (SPG17) or Silver syndrome.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of a gene. It can identify mutations or variations in the BSCL2 gene that may be associated with SPG17. NGS testing is a powerful tool that allows for the analysis of multiple genes simultaneously, providing a comprehensive evaluation of an individual’s genetic makeup.

Genetic testing for SPG17 can be done through a blood or saliva sample. The sample is sent to a laboratory where the DNA is extracted and analyzed using NGS technology. The results of the test can help diagnose SPG17 and provide information about the specific mutation present in the BSCL2 gene.

Genetic testing for SPG17 can be useful for individuals who have symptoms consistent with the disorder, as well as for family members of affected individuals who may be at risk of inheriting the mutation. It can also be used for carrier testing in individuals with a family history of SPG17, to determine if they carry a mutation in the BSCL2 gene.

It is important to note that genetic testing for SPG17 is typically ordered by a healthcare professional, such as a geneticist or neurologist, who can interpret the results and provide appropriate counseling and guidance.

Test Name	BSCL2 Gene SPG17 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for BSCL2 Gene SPG17 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with BSCL2 Gene SPG17
Test Details	The BSCL2 gene, also known as SPG17, is responsible for producing a protein called seipin. Mutations in the BSCL2 gene can lead to a rare neurological disorder called spastic paraplegia type 17 (SPG17) or Silver syndrome. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of a gene. It can identify mutations or variations in the BSCL2 gene that may be associated with SPG17. NGS testing is a powerful tool that allows for the analysis of multiple genes simultaneously, providing a comprehensive evaluation of an individual’s genetic makeup. Genetic testing for SPG17 can be done through a blood or saliva sample. The sample is sent to a laboratory where the DNA is extracted and analyzed using NGS technology. The results of the test can help diagnose SPG17 and provide information about the specific mutation present in the BSCL2 gene. Genetic testing for SPG17 can be useful for individuals who have symptoms consistent with the disorder, as well as for family members of affected individuals who may be at risk of inheriting the mutation. It can also be used for carrier testing in individuals with a family history of SPG17, to determine if they carry a mutation in the BSCL2 gene. It is important to note that genetic testing for SPG17 is typically ordered by a healthcare professional, such as a geneticist or neurologist, who can interpret the results and provide appropriate counseling and guidance.

Browse

Want to chat?

Social